David Gastfriend

Citée par

	Toutes	Depuis 2019
Citations	13639	2559
indice h	50	22
indice i10	108	47

740

370

185

555

19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202445 63 52 102 127 170 203 285 339 370 403 487 643 657 610 653 691 683 670 723 690 623 600 665 560 496 481 452 425 145

Accès public

Tout afficher

16 articles

2 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Roger WeissChief, Division of Alchol, Drugs, and Addiction, McLean Hospital; Professor of Psychiatry, Harvard Medical SchoolAdresse e-mail validée de mclean.harvard.edu
Paul Crits-ChristophUniversity of PennsylvaniaAdresse e-mail validée de mail.med.upenn.edu
Henry R. KranzlerCenter for Studies of Addiction, University of Pennsylvania Perelman School of MedicineAdresse e-mail validée de pennmedicine.upenn.edu
Hans BreiterDirector, MGH Phenotype Genotype Project in Addiction and Mood DisordersAdresse e-mail validée de partners.org
Jacques P. BarberProfessor and former Dean, Gordon F. Derner School of Psychology, Adelphi UniversityAdresse e-mail validée de adelphi.edu
Evgeny KrupitskyHead, Department of Addictions, V.M. Bekhterev National Medical Reserach Center for Psychiatry andAdresse e-mail validée de ek3506.spb.edu
Lisa NajavitsProfessor of Psychiatry, Boston University School of MedicineAdresse e-mail validée de treatment-innovations.org
Bruce RosenMGH/HST Athinoula A. Martinos Center for Biomedical ImagingAdresse e-mail validée de mgh.harvard.edu
Randy GollubProfessor of Psychiatry, Harvard Medical SchoolAdresse e-mail validée de partners.org
Robert SwiftBrown University Center for Alcohol and Addiction StudiesAdresse e-mail validée de brown.edu
Dennis DonovanUniversity of WashingtonAdresse e-mail validée de u.washington.edu
Nikos MakrisProfessor of Psychiatry, Harvard Medical SchoolAdresse e-mail validée de mgh.harvard.edu
David N. KennedyProfessor, Department of Psychiatry, University of Massachusetts Medical SchoolAdresse e-mail validée de umassmed.edu
Steven E. HymanProfessor of Stem Cell and Regenerative Biology, Harvard University; Director Stanley Center forAdresse e-mail validée de broadinstitute.org
Barbara J. MasonThe Scripps Research InstituteAdresse e-mail validée de scripps.edu
Sharon ReifBrandeis UniversityAdresse e-mail validée de brandeis.edu
Katherine KarlsgodtUniversity of California, Los AngelesAdresse e-mail validée de psych.ucla.edu
Robert F. Forman, Ph.D.AlkermesAdresse e-mail validée de alkermes.com
Asli MemisogluSenior Director Biostatistics, Alkermes Inc.Adresse e-mail validée de alkermes.com
Josh BerkeProfessor of Neurology and Psychiatry, UCSFAdresse e-mail validée de ucsf.edu

Suivre

David Gastfriend

DynamiCare Health, Inc.

Adresse e-mail validée de DynamiCareHealth.com - Page d'accueil

Substance Use Disorders


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial RF Anton, SS O’Malley, DA Ciraulo, RA Cisler, D Couper, DM Donovan, ... Jama 295 (17), 2003-2017, 2006	2162	2006
Acute effects of cocaine on human brain activity and emotion HC Breiter, RL Gollub, RM Weisskoff, DN Kennedy, N Makris, JD Berke, ... Neuron 19 (3), 591-611, 1997	1702	1997
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial JC Garbutt, HR Kranzler, SS O’Malley, DR Gastfriend, HM Pettinati, ... Jama 293 (13), 1617-1625, 2005	809	2005
Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse collaborative cocaine treatment study P Crits-Christoph, L Siqueland, J Blaine, A Frank, L Luborsky, LS Onken, ... Archives of general psychiatry 56 (6), 493-502, 1999	755	1999
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial E Krupitsky, EV Nunes, W Ling, A Illeperuma, DR Gastfriend, ... The Lancet 377 (9776), 1506-1513, 2011	664	2011
The glutamatergic basis of human alcoholism. G Tsai, DR Gastfriend, JT Coyle The American journal of psychiatry 152 (3), 332-340, 1995	552	1995
The Addiction Severity Index A field study of internal consistency and validity C Leonhard, K Mulvey, DR Gastfriend, M Shwartz Journal of Substance Abuse Treatment 18 (2), 129-135, 2000	343	2000
Cocaine dependence with and without PTSD among subjects in the National Institute on Drug Abuse Collaborative Cocaine Treatment Study LM Najavits, DR Gastfriend, JP Barber, S Reif, LR Muenz, J Blaine, ... American Journal of Psychiatry 155 (2), 214-219, 1998	303	1998
The ASAM criteria: Treatment for addictive, substance-related, and co-occurring conditions D Mee-Lee, GD Shulman, MJ Fishman, DR Gastfriend, MM Miller, ... American Society of Addiction Medicine, 2013	232	2013
Decreased absolute amygdala volume in cocaine addicts N Makris, GP Gasic, LJ Seidman, JM Goldstein, DR Gastfriend, I Elman, ... Neuron 44 (4), 729-740, 2004	203	2004
Addiction denial and cognitive dysfunction: a preliminary investigation W Rinn, N Desai, H Rosenblatt, DR Gastfriend The Journal of neuropsychiatry and clinical neurosciences 14 (1), 52-57, 2002	192	2002
Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence I Elman, KH Karlsgodt, DR Gastfriend The American journal of drug and alcohol abuse 27 (2), 193-202, 2001	183	2001
The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use RD Weiss, ML Griffin, C Mazurick, B Berkman, DR Gastfriend, A Frank, ... American Journal of Psychiatry 160 (7), 1320-1325, 2003	173	2003
Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment SS O'Malley, JC Garbutt, DR Gastfriend, Q Dong, HR Kranzler Journal of clinical psychopharmacology 27 (5), 507-512, 2007	167	2007
The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients RD Weiss, ML Griffin, RJ Gallop, LM Najavits, A Frank, P Crits-Christoph, ... Drug and Alcohol Dependence 77 (2), 177-184, 2005	166	2005
Reduction in heavy drinking as a treatment outcome in alcohol dependence DR Gastfriend, JC Garbutt, HM Pettinati, RF Forman Journal of substance abuse treatment 33 (1), 71-80, 2007	151	2007
Developing performance measures for alcohol and other drug services in managed care plans F McCorry, DW Garnick, J Bartlett, F Cotter, M Chalk, T Babor, S Falcon, ... The Joint Commission Journal on Quality Improvement 26 (11), 633-643, 2000	151	2000
Establishing the feasibility of performance measures for alcohol and other drugs DW Garnick, MT Lee, M Chalk, D Gastfriend, CM Horgan, F McCorry, ... Journal of substance abuse treatment 23 (4), 375-385, 2002	150	2002
A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence RF Anton, H Pettinati, A Zweben, HR Kranzler, B Johnson, MJ Bohn, ... Journal of clinical psychopharmacology 24 (4), 421-428, 2004	149	2004
The National Institute on Drug Abuse Collaborative Cocaine Treatment Study: Rationale and methods P Crits-Christoph, L Siqueland, J Blaine, A Frank, L Luborsky, LS Onken, ... Archives of General Psychiatry 54 (8), 721-726, 1997	146	1997

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs